Save the date! We invite you to join Oncology Nursing News for an #OncNurseConnect Tweet Chat on Thursday, February 27, at 1 p.m. EST, when we plan on discussing the popular topics in nursing covered in our latest issue.
Save the date! We invite you to join Oncology Nursing News for an #OncNurseConnect Tweet Chat on Thursday, February 27, at 1 p.m. EST, when we plan on discussing the popular topics in nursing covered in our February issue.
Each quarter, we host an #OncNurseConnect Tweet Chat to bring together nursing professionals and others in the cancer care space to promote collaboration within the community. This chat will be focused on popular topics in oncology nursing, from global healthcare to workplace diversity and more. During the chat, we’ll ask the following questions:
Never participated in a Tweet Chat before? It’s simple!
We'll see you on Twitter!
FDA Grants Full Approval to Mirvetuximab Soravtansine for Pretreated Gynecologic Cancers
March 22nd 2024Mirvetuximab soravtansine received full approval from the FDA for pretreated adult patients with FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Immunotherapy May Address ‘Huge Need’ in Advanced Endometrial Cancer
March 22nd 2024Amanda Duck, PA-C, RD, held a discussion during a Community Case Forum on the progress made in using immunotherapy to treat patients with advanced endometrial cancer and the creativity sometimes needed to address adverse events.